Vivani Medical
VANI
35 hedge funds and large institutions have $3.83M invested in Vivani Medical in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
325% more call options, than puts
Call options by funds: $34K | Put options by funds: $8K
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
25% more funds holding
Funds holding: 28 → 35 (+7)
24.6% less ownership
Funds ownership: 33.54% → 8.94% (-25%)
62% less capital invested
Capital invested by funds: $10M → $3.83M (-$6.21M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
EW
Evoke Wealth
Los Angeles,
California
|
+$220K |
| 2 |
Millennium Management
New York
|
+$193K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$119K |
| 4 |
Renaissance Technologies
New York
|
+$92.2K |
| 5 |
Jane Street
New York
|
+$36K |
Top Sellers
VANI Hedge Fund Activity: Q4 2022 in Review
35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2022, worth a combined $3.83M — down 62% from $10M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VANI positions and 4 closed out — a net gain of 7 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Evoke Wealth, opening a new position worth an estimated $220K. The largest seller was Tanager Wealth Management, cutting an estimated $411K.
- 35 institutional investors held Vivani Medical (VANI) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $3.83M of Vivani Medical stock for Q4 2022, down 62% quarter-over-quarter.
- 11 funds opened new Vivani Medical positions in Q4 2022 and 4 closed out, a net change of +7 holders.
- The largest Vivani Medical buyer in Q4 2022 was Evoke Wealth, an estimated $220K added.
- The largest Vivani Medical seller in Q4 2022 was Tanager Wealth Management, an estimated $411K sold.
Based on aggregated 13F filings for Q4 2022.